Disproportionate alterations in body composition of large for gestational age neonates

M Hammami1, J C Walters, E M Hockman

  • 1Department of Pediatrics, University of Tennessee, Memphis, TN, USA.

Insights

Large for gestational age (LGA) neonates exhibit increased body fat and reduced lean body mass compared to appropriate for gestational age (AGA) infants. Maternal glucose intolerance further amplifies these body composition differences.

Area of Science:

  • Neonatal physiology
  • Pediatric endocrinology
  • Body composition analysis

Background:

  • Neonatal birth weight classification (Large for Gestational Age - LGA, Appropriate for Gestational Age - AGA) is crucial for identifying potential health risks.
  • Body composition differences between LGA and AGA neonates are not fully understood.
  • Maternal health conditions, such as diabetes, can influence fetal growth and neonatal body composition.

Purpose of the Study:

  • To compare the body composition of LGA and AGA neonates using dual-energy x-ray absorptiometry (DXA).
  • To investigate the impact of maternal glucose intolerance on neonatal body composition in LGA infants.

Main Methods:

  • Comparative study design involving LGA and AGA term infants.
  • Dual-energy x-ray absorptiometry (DXA) scans performed within the first few days of life.
  • Analysis included body weight, length, total body fat, lean body mass, and bone mineral content.

Main Results:

  • LGA neonates demonstrated significantly higher absolute amounts and proportions of total body fat and bone mineral content compared to AGA neonates.
  • LGA neonates showed significantly lower lean body mass as a percentage of body weight.
  • Infants classified as LGA born to mothers with impaired glucose tolerance exhibited the most pronounced changes in body fat and lean body mass percentages.

Conclusions:

  • LGA neonates possess distinct body composition profiles characterized by increased adiposity and decreased relative lean mass compared to AGA infants.
  • Impaired maternal glucose tolerance significantly exacerbates these body composition alterations in LGA neonates.
  • These findings highlight the importance of monitoring maternal metabolic health during pregnancy for neonatal outcomes.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...